Wet age-related macular degeneration (AMD)

Clinical trials for Wet age-related macular degeneration (AMD) explained in plain language.

Never miss a new study

Get alerted when new Wet age-related macular degeneration (AMD) trials appear

Sign up with your email to follow new studies for Wet age-related macular degeneration (AMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a simple pill help save sight in wet AMD?

Disease control Recruiting now

This study tests an experimental oral tablet called HX9428 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The trial will enroll 198 adults aged 50–85 to check the drug's safety, how the body processes it, and whether it can improve eye…

Matched conditions: WET AGE-RELATED MACULAR DEGENERATION (AMD)

Phase 1/2 • Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

Wet age-related macular degeneration (AMD)

Get alerted when new Wet age-related macular degeneration (AMD) trials appear

Could a simple pill help save sight in wet AMD?